EcoDrugPlus

Thyroid Hormone Receptor Beta

Ensembl ID : ENSDARG00000021163
Gene Symbol: THRB
9 Enzyme and pathways 5 Cross references
393 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor A

Ensembl ID : ENSDARG00000076546
Gene Symbol: TRHRA
5 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSDARG00000036159
Gene Symbol: TRHRB
7 Enzyme and pathways 5 Cross references
194 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSDARG00000037758
Gene Symbol: TLR2
5 Enzyme and pathways 5 Cross references
210 Possible Orthologues:

Toll-Like Receptor 7

Ensembl ID : ENSDARG00000068812
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Trace Amine Associated Receptor 1b

Ensembl ID : ENSDARG00000089000
Gene Symbol: TAAR1B
7 Enzyme and pathways 5 Cross references
149 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 A

Ensembl ID : ENSDARG00000017494
Gene Symbol: TGFBR1A
5 Cross references
161 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSDARG00000042259
Gene Symbol: TGFBR1B
10 Enzyme and pathways 5 Cross references
208 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1a

Ensembl ID : ENSDARG00000016699
Gene Symbol: TRPA1A
4 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSDARG00000031875
Gene Symbol: TRPA1B
4 Enzyme and pathways 5 Cross references
201 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSDARG00000037191
Gene Symbol: TTR
13 Enzyme and pathways 5 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSDARG00000029432
Gene Symbol: TPH1A
4 Enzyme and pathways 5 Cross references
214 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).